【原著論文】
Zhou H, Xie Z, Morikawa N, Sakurai F, Mizuguchi H, Okuzaki D, Okada N, Tachibana M. (corresponding author)
Modified method for differentiation of myeloid-derived suppressor cells in vitro enhances immunosuppressive ability via glutathione metabolism.
Biochem Biophys Rep. 2022;33:101416.

Hirobe S, Nagai S, Tachibana M, Okada N.
Binding and Efficacy of Anti-Robo4 CAR-T Cells against Solid Tumors.
Biomedicines. 2022;10(6):1273.

Xie Z, Kawasaki T, Zhou H, Okuzaki D, Okada N, Tachibana M. (corresponding author)
Targeting GGT1 Eliminates the Tumor-Promoting Effect and Enhanced Immunosuppressive Function of Myeloid-Derived Suppressor Cells Caused by G-CSF. Front Pharmacol. 2022;13:873792.

Hirobe S, Imaeda K, Tachibana M, Okada N.
The Effects of Chimeric Antigen Receptor (CAR) Hinge Domain Post-Translational Modifications on CAR-T Cell Activity.
Int J Mol Sci. 2022;23(7):4056.

Hirobe S, Yamasaki T, Ito S, Quan YS, Kamiyama F, Tachibana M, Okada N.
Transcutaneous Administration of Imiquimod Promotes T and B Cell Differentiation into Effector Cells or Plasma Cells.
Pharmaceutics. 2022;14(2):385.

Ito S, Hirobe S, Yamashita R, Sugiyama A, Takeuchi H, Eguchi R, Yoshida J, Oyamada T, Tachibana M, Okada N.
Analysis of immune response induction mechanisms implicating the dose-sparing effect of transcutaneous immunization using a self-dissolving microneedle patch.
Vaccine. 2022:S0264-410X(21)01663-7.
 
【総説論文】
水口裕之、立花雅史、櫻井文教
アデノウイルスベクターワクチンの現状と展望
Drug Delivery System、2022; 37(5):421-28.

Sakurai F, Tachibana M, Mizuguchi H.
Adenovirus vector-based vaccine for infectious diseases.
Drug Metab Pharmacokinet. 2022;42:100432